One Ship, a Worldwide Crisis: How Can Supply Chains Get Unstuck?

Data drives decisions of the worlds largest companies but in a world with constant data, how do you make sense of it? Host TC Riley, puts the world under the lens of data and analytics and explores current news, B2B trends, and popular topics.

 

The Ever Given will go down in infamy, and not in a good way. Its blockage of the Suez Canal further crippled supply chains already at their breaking points due to the pandemic. How could one incident have such an impact? It’s all clear when diving into the data, and that’s what host TC Riley does in this episode.

“You can’t underestimate the importance of the Suez Canal to global trade. It cuts 3500 nautical miles and around nine days off the trip between Asia and Europe,” Riley said. The number of shipments that pass through it every day is incredible. Over 1,000,000 barrels of oil and 8% of the world’s liquified natural gas go through it daily. During the debacle, the media went in on the economics, most saying it cost the world billions.

The reality may look a little different. “It was a significant shock to global trade, impacting many businesses, but these numbers are drastically blown out of proportion,” Riley explained. It’s more likely that the true economic consequences won’t be known for some time. Riley called it “an excellent example of data not being incorrect but applied inappropriately.”

While this is an extreme example, businesses do this all the time. So, what’s the real impact? What experts can say is that it affected operating costs for shipping companies, primarily in fuel costs. Another area is insurance premiums, as insurance companies were hit hard by the blockage. For the consumer, it may be negligible or show up in temporary oil price increases.

“The biggest takeaway for me is the impact that global supply chains have on so many businesses and how fragile some of those chains are,” Riley remarked. The data won’t be in for some time, and that’s the story with most global emergencies. It’s a good reminder to take in the entire picture that data paints before drawing finite conclusions.

Catch up on all episodes of Diving Into Data!

Follow us on social media for the latest updates in B2B!

Image

Latest

Doable
Rethinking Leadership: Why “Doable” Might Be the Most Powerful Strategy in Education Today
April 3, 2026

At a time when educator burnout is rising and schools across the U.S. are facing ongoing teacher shortages, leaders are being forced to rethink what sustainable success actually looks like. Research shows that teacher attrition is closely tied to working conditions, job-related stress, and workload demands. As districts push for innovation, data-driven instruction, and…

Read More
Casey Brown
From Poverty to Pricing Power | Why Great Companies Undercharge
April 2, 2026

Casey Brown didn’t grow up thinking she would become an entrepreneur. She grew up in a blue-collar family where money was always tight — close enough to the edge that the fear of poverty shaped many of her early decisions. That fear led her into engineering, into corporate America, and eventually into a moment…

Read More
Nightingales Summit: Empowering the Next Generation of Nigerian Nurses
Nightingales Summit: Empowering the Next Generation of Nigerian Nurses
April 2, 2026

In this episode of Care Anywhere, host Lea Sims sits down with Nigerian nurse entrepreneur and advocate Obafemi Arowosegbe to discuss leadership, mentorship, and the future of nursing in Africa. While still a nursing student, Obafemi founded the Nightingale Summit, a growing conference designed to empower nursing students and early-career nurses with leadership skills,…

Read More
Oncology
From Denial to Access: Rethinking Oncology Care Through AI, Clinical Trials, and Patient-Centered Innovation
April 1, 2026

The rapid expansion of precision medicine, biologics, and targeted cancer therapies is transforming oncology—but it’s also overwhelming a system not built to keep pace. In the U.S., cancer drugs now account for some of the highest-cost treatments in healthcare, and with that has come a surge in prior authorization requirements and denials. Studies suggest physicians…

Read More